Johnson & Johnson (JNJ) said near deal for Abbott's (ABT) eye-surgery unit - DJ
- Wall Street rallies as OPEC reaches output deal
- Pier 1 Imports (PIR) Reports In-Line Q2 EPS; Comps Fall 4.3%
- Intra-Cellular Therapies (ITCI) Announces ITI-007 Phase 3 Missed Primary Endpoint in Schizophrenia
- Vertex Pharma (VRTX) Announces FDA Approval for ORKAMBI in Children 6-11; Lowers 2016 ORKAMBI Revenue Outlook
- After-Hours Stock Movers 09/28: (AEGR) (PIR) (GSAT) Higher; (ITCI) (ATNM) (PRGS) Lower (more...)
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Scottrade Said to Attract Interest from TD Ameritrade (AMTD) - Bloomberg
- Interactive Brokers (IBKR) Ticks Higher on Industry Chatter
- Janssen-Cilag Will Present Oncology Data at ESMO 2016
Create E-mail Alert Related CategoriesMergers and Acquisitions, Rumors, Spinoffs, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!